12 September 2023
Quadrise Plc
("Quadrise" or the "Company")
Morocco Project Update
Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its fuel trial in Morocco.
Following the earthquake in Morocco on Friday evening, the Quadrise team would like to extend their sympathies to all of those affected.
The Company remains in close touch with the client and notes that the client team and operations at the fuel trial site were not impacted by the earthquake. The Company continues to monitor the situation closely.
A Quadrise team is now on site installing and commissioning the replacement pump. The trial will re-commence at the next available client production window now estimated to be early October 2023.
Change of Name of Nominated Adviser
The Company also announces that its Nominated Adviser has changed its name to Cavendish Securities plc following the completion of its own corporate merger.
For additional information, please contact:
| Quadrise Plc | | +44 (0)20 7031 7321 |
| Andy Morrison, Chairman Jason Miles, Chief Executive Officer | | |
| | | |
| Nominated Adviser | | |
| Cavendish Securities plc | | +44 (0)20 7220 0500 |
| Ben Jeynes | | |
| Katy Birkin | | |
| Joint Brokers Shore Capital Stockbrokers Limited | |
+44 (0)20 7408 4090 |
| Toby Gibbs, Rachel Goldstein (Corporate Advisory) | | |
| Fiona Conroy (Corporate Broking) | | |
|
|
|
|
| VSA Capital Limited Andrew Raca (Corporate Finance) Andrew Monk (Corporate Broking) | | +44 (0)20 3005 5000 |
| | | |
| Public & Investor Relations |
|
|
| Vigo Consulting Patrick D'Ancona Finlay Thomson | | +44 (0)20 7390 0230 |
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.
Learn more at: www.quadrise.com
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.